ES2089196T3 - Derivados de la vasotocina vasoactiva. - Google Patents

Derivados de la vasotocina vasoactiva.

Info

Publication number
ES2089196T3
ES2089196T3 ES91905375T ES91905375T ES2089196T3 ES 2089196 T3 ES2089196 T3 ES 2089196T3 ES 91905375 T ES91905375 T ES 91905375T ES 91905375 T ES91905375 T ES 91905375T ES 2089196 T3 ES2089196 T3 ES 2089196T3
Authority
ES
Spain
Prior art keywords
pct
derivatives
image
present
vasotocin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91905375T
Other languages
English (en)
Inventor
Carl-Johan Aurell
Per Melin
Anders Nilsson
Jerzy Trojnar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring AB
Original Assignee
Ferring AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring AB filed Critical Ferring AB
Application granted granted Critical
Publication of ES2089196T3 publication Critical patent/ES2089196T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

SE PRESENTAN DERIVADOS DE LA VASOTOCINA DE LA FORMULA (I), EN LA QUE HMP = UN RESIDUO DE ACIDO 2 ROPIONICO (A), Z = PHE O TYR, Y = HGN O HCI, X = (B), Q = H O ENTRE 1 Y 3 RESIDUOS DE ACIDO AMINO DE LOS MISMOS O DIFERENTES ACIDOS L 3. UN COMPUESTO FARMACEUTICO QUE COMPRENDE AL MENOS UN DERIVADO DE LA VASOTICINA SEGUN SE HA DEFINIDO ANTERIORMENTE SE USA COMO AGENTE VOSOCONSTRICOR.
ES91905375T 1990-02-27 1991-02-26 Derivados de la vasotocina vasoactiva. Expired - Lifetime ES2089196T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000691A SE502644C2 (sv) 1990-02-27 1990-02-27 Vasoaktiva vasotocinderivat

Publications (1)

Publication Number Publication Date
ES2089196T3 true ES2089196T3 (es) 1996-10-01

Family

ID=20378692

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91905375T Expired - Lifetime ES2089196T3 (es) 1990-02-27 1991-02-26 Derivados de la vasotocina vasoactiva.

Country Status (19)

Country Link
US (1) US5459236A (es)
EP (1) EP0517778B1 (es)
JP (1) JP2957275B2 (es)
KR (1) KR0171614B1 (es)
AT (1) ATE137764T1 (es)
AU (1) AU633198B2 (es)
CA (1) CA2076749C (es)
DE (1) DE69119409T2 (es)
DK (1) DK0517778T3 (es)
ES (1) ES2089196T3 (es)
FI (1) FI109703B (es)
HU (1) HU215121B (es)
IE (1) IE62345B1 (es)
IL (1) IL97298A (es)
MC (1) MC2254A1 (es)
NO (1) NO923333L (es)
RU (1) RU2067586C1 (es)
SE (1) SE502644C2 (es)
WO (1) WO1991013092A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
ATE193892T1 (de) * 1993-06-29 2000-06-15 Ferring Bv Synthese zyklischer peptide
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
AU2007215406B2 (en) * 2006-02-10 2011-12-08 Ferring B.V Novel compounds
EP2175874A2 (en) * 2007-08-14 2010-04-21 Ferring B.V. Use of peptidic vasopressin receptor agonists
RU2454426C1 (ru) * 2011-04-06 2012-06-27 Федеральное государственное образовательное учреждение высшего профессионального образования Санкт-Петербургский государственный университет Пептид калий-уретический
KR101304427B1 (ko) 2011-04-12 2013-09-05 한국과학기술연구원 재사용이 용이한 기공체 - 위성 나노입자 복합체 및 그 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1246055A (en) * 1980-03-24 1988-12-06 Joseph H. Cort N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs
SE469473B (sv) * 1987-10-07 1993-07-12 Ferring Ab Vasoaktiva peptider

Also Published As

Publication number Publication date
MC2254A1 (fr) 1993-03-25
JPH05504575A (ja) 1993-07-15
DK0517778T3 (da) 1996-08-19
DE69119409T2 (de) 1996-09-05
SE502644C2 (sv) 1995-11-27
WO1991013092A1 (en) 1991-09-05
FI923820A0 (fi) 1992-08-26
NO923333L (no) 1992-10-16
EP0517778B1 (en) 1996-05-08
DE69119409D1 (de) 1996-06-13
KR0171614B1 (ko) 1999-02-01
EP0517778A1 (en) 1992-12-16
AU633198B2 (en) 1993-01-21
RU2067586C1 (ru) 1996-10-10
SE9000691L (sv) 1991-08-28
SE9000691D0 (sv) 1990-02-27
AU7342491A (en) 1991-09-18
HU215121B (hu) 1998-09-28
IE62345B1 (en) 1995-01-25
NO923333D0 (no) 1992-08-26
IE910648A1 (en) 1991-08-28
HUT61580A (en) 1993-01-28
KR920703003A (ko) 1992-12-17
JP2957275B2 (ja) 1999-10-04
ATE137764T1 (de) 1996-05-15
FI109703B (fi) 2002-09-30
CA2076749C (en) 2001-02-20
IL97298A0 (en) 1992-05-25
IL97298A (en) 1995-08-31
CA2076749A1 (en) 1991-08-28
US5459236A (en) 1995-10-17
HU9202748D0 (en) 1992-12-28
FI923820A (fi) 1992-08-26

Similar Documents

Publication Publication Date Title
HU9601218D0 (en) Distamycin a analogue utilizable as antitumoral and antiviral medicines
TW334418B (en) Stilbene derivatives and pharmaceutical compositions
AU646314B2 (en) Bi(aromatic) compounds and their use in human and veterinary medicine and in cosmetic preparations
IT1295694B1 (it) Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
MX9801716A (es) Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
NZ210627A (en) 11-beta-arylestradienes and pharmaceutical compositions
TR199901305T2 (xx) Calpain-�nleyicileri olarak ketonbenzamidler
SE9604341D0 (sv) Hepta-peptide oxytocin analogue
DE69326250D1 (de) Neuropeptide y antagoniste
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
IN186299B (es)
ES2131528T3 (es) Nuevos polipeptidos y su uso.
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
ES2089196T3 (es) Derivados de la vasotocina vasoactiva.
HK56597A (en) 3-aminochromane derivatives procedure for their preparation and pharmaceutical compositions containing them
ZA897949B (en) Pharmaceutical composition containing nitroxyalkylamines and new nitroxyalkylamines
ES2074264T3 (es) Esteres de aminoacidos de la hidroquinona, su procedimiento de preparacion y composiciones farmaceuticas o cosmeticas que los contienen.
DK87090D0 (da) Vasotocin-derivater og farmaceutiske midler indeholdende saadanne derivater
DE3855751T2 (de) Hypoglycemische peptide

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 517778

Country of ref document: ES

FG2A Definitive protection

Ref document number: 517778

Country of ref document: ES